JP2019214632A5 - - Google Patents

Download PDF

Info

Publication number
JP2019214632A5
JP2019214632A5 JP2019181618A JP2019181618A JP2019214632A5 JP 2019214632 A5 JP2019214632 A5 JP 2019214632A5 JP 2019181618 A JP2019181618 A JP 2019181618A JP 2019181618 A JP2019181618 A JP 2019181618A JP 2019214632 A5 JP2019214632 A5 JP 2019214632A5
Authority
JP
Japan
Prior art keywords
composition
hyaluronan
concentration
elasticity
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019181618A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019214632A (ja
JP7025039B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019214632A publication Critical patent/JP2019214632A/ja
Publication of JP2019214632A5 publication Critical patent/JP2019214632A5/ja
Priority to JP2022015509A priority Critical patent/JP2022058871A/ja
Application granted granted Critical
Publication of JP7025039B2 publication Critical patent/JP7025039B2/ja
Priority to JP2024010878A priority patent/JP2024028669A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019181618A 2013-07-10 2019-10-01 高い弾性を有するヒアルロナンの組成物およびその使用 Active JP7025039B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022015509A JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用
JP2024010878A JP2024028669A (ja) 2013-07-10 2024-01-29 高い弾性を有するヒアルロナンの組成物およびその使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361844645P 2013-07-10 2013-07-10
US61/844,645 2013-07-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018114766A Division JP6598929B2 (ja) 2013-07-10 2018-06-15 高い弾性を有するヒアルロナンの組成物およびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022015509A Division JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2019214632A JP2019214632A (ja) 2019-12-19
JP2019214632A5 true JP2019214632A5 (cg-RX-API-DMAC7.html) 2020-02-06
JP7025039B2 JP7025039B2 (ja) 2022-02-24

Family

ID=51261252

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016525455A Active JP6357228B2 (ja) 2013-07-10 2014-07-09 高い弾性を有するヒアルロナンの組成物およびその使用
JP2018114766A Active JP6598929B2 (ja) 2013-07-10 2018-06-15 高い弾性を有するヒアルロナンの組成物およびその使用
JP2019181618A Active JP7025039B2 (ja) 2013-07-10 2019-10-01 高い弾性を有するヒアルロナンの組成物およびその使用
JP2022015509A Withdrawn JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用
JP2024010878A Pending JP2024028669A (ja) 2013-07-10 2024-01-29 高い弾性を有するヒアルロナンの組成物およびその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016525455A Active JP6357228B2 (ja) 2013-07-10 2014-07-09 高い弾性を有するヒアルロナンの組成物およびその使用
JP2018114766A Active JP6598929B2 (ja) 2013-07-10 2018-06-15 高い弾性を有するヒアルロナンの組成物およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022015509A Withdrawn JP2022058871A (ja) 2013-07-10 2022-02-03 高い弾性を有するヒアルロナンの組成物およびその使用
JP2024010878A Pending JP2024028669A (ja) 2013-07-10 2024-01-29 高い弾性を有するヒアルロナンの組成物およびその使用

Country Status (8)

Country Link
US (5) US9492474B2 (cg-RX-API-DMAC7.html)
EP (3) EP3019177B1 (cg-RX-API-DMAC7.html)
JP (5) JP6357228B2 (cg-RX-API-DMAC7.html)
AR (2) AR096875A1 (cg-RX-API-DMAC7.html)
ES (2) ES2837626T3 (cg-RX-API-DMAC7.html)
PL (2) PL3613423T3 (cg-RX-API-DMAC7.html)
PT (2) PT3019177T (cg-RX-API-DMAC7.html)
WO (1) WO2015006460A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3019177T (pt) 2013-07-10 2020-12-30 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
ES2871199T3 (es) * 2015-09-24 2021-10-28 Matrix Biology Inst Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas
CN112055564B (zh) 2018-01-10 2024-08-23 都柏林圣三一学院教务长研究员学者及董事会其他成员 用于封闭组织中的通道的系统和方法
WO2020144372A1 (en) 2019-01-10 2020-07-16 The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin Composite viscoelastic hydrogel, and uses thereof for sealing a channel in tissue
WO2019202017A1 (en) 2018-04-18 2019-10-24 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
CA3140715A1 (en) * 2019-05-17 2020-11-26 The Governing Council Of The University Of Toronto Sustained release local anesthetic hydrogel composition

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
CH666897A5 (fr) 1983-10-11 1988-08-31 Fidia Spa Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
AU620821B2 (en) 1987-08-25 1992-02-27 Macnaught Pty Limited Hyaluronic acid lubricating compounds
US5403592A (en) 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
EP0414373B2 (en) * 1989-07-24 2001-04-25 Allergan Pharmaceuticals (Ireland) Limited Stable solution of hyaluronate in a balanced salt medium
CA2060223C (en) 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5234914A (en) 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
AU682670B2 (en) 1993-02-05 1997-10-16 Becton Dickinson & Company Syringe needle isolation device
US5624915A (en) 1993-08-04 1997-04-29 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5607400A (en) 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
JPH09173450A (ja) 1995-12-26 1997-07-08 Nissho Corp プレフィルドシリンジ
JP3293122B2 (ja) 1996-12-13 2002-06-17 ニプロ株式会社 プレフィルドシリンジ
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
RU2126669C1 (ru) 1997-04-25 1999-02-27 Новокузнецкий государственный институт усовершенствования врачей Способ лечения синдрома сухого глаза
SE9703425D0 (sv) 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
DE19751219A1 (de) 1997-11-19 1999-05-27 Vetter & Co Apotheker Spritze, insbesondere vorgefüllte Spritze, oder Karpule
JP4790120B2 (ja) 1998-03-13 2011-10-12 ベクトン・ディキンソン・アンド・カンパニー 医療容器の製造、充填および包装方法
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
JP3591636B2 (ja) 2000-04-03 2004-11-24 ニプロ株式会社 プレフィルドシリンジ
TR200302105T4 (tr) 2000-04-07 2004-02-23 Laboratoire Medidom S. A. Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
US7635489B2 (en) 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
JP2003119147A (ja) * 2001-10-10 2003-04-23 Raku:Kk ヒアルロン酸化合物の水溶液組成物
CA2458126C (en) 2001-11-21 2012-06-26 Novartis Ag Composition for stabilizing hyaluronic acid
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
JP4141156B2 (ja) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 プランジャ後退制限機構付きプレフィルドシリンジ
EP2386326B1 (en) 2002-07-02 2013-01-09 Terumo Kabushiki Kaisha Syringe and prefilled syringe
CN103638040A (zh) 2002-07-03 2014-03-19 派瑞克科学公司 透明质酸组合物以及使用方法
WO2004028536A1 (en) 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
DE10254321A1 (de) 2002-11-21 2004-06-17 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Vorgefüllte Spritze
JP2004229750A (ja) 2003-01-28 2004-08-19 Nipro Corp プレフィルドシリンジ及びそのバレルの製造方法
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
JP2004262777A (ja) 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AR044302A1 (es) 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
US20050059639A1 (en) 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US20050075611A1 (en) 2003-10-01 2005-04-07 Hetzler Kevin G. Low extractable, thermoplastic syringe and tip cap
US20090148527A1 (en) 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
CA2565944C (en) 2004-05-07 2011-07-19 S.K. Pharmaceuticals, Inc. Stabilized hyaluronan preparations and related methods
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
WO2006067608A1 (en) 2004-12-22 2006-06-29 Laboratoire Medidom S.A. Aqueous formulations based on sodium hyaluronate for parenteral use
CN101094680A (zh) 2004-12-30 2007-12-26 建新公司 用于关节内粘弹性补充的方案
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
US7767710B2 (en) 2005-05-25 2010-08-03 Calosyn Pharma, Inc. Method for treating osteoarthritis
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
JP2009516765A (ja) * 2005-11-22 2009-04-23 サントル ナシオナル ドゥ ラ ルシェルシェ シアンティフィク 新規ヒアルロン酸誘導体、その製造方法及びその使用
US7988675B2 (en) 2005-12-08 2011-08-02 West Pharmaceutical Services Of Delaware, Inc. Automatic injection and retraction devices for use with pre-filled syringe cartridges
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
JP4682850B2 (ja) 2006-01-12 2011-05-11 ニプロ株式会社 プレフィルドシリンジ
JP2009524692A (ja) 2006-01-25 2009-07-02 アーシエックス, インコーポレイテッド ドライアイのための処方物および方法
US7674781B2 (en) 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
WO2008011836A2 (es) 2006-07-25 2008-01-31 Osmotica Corp. Soluciones oftálmicas
EP2059206B8 (en) 2006-08-28 2012-07-11 Rexaderm, Inc. Dry wound dressing and drug delivery system
ITMI20061668A1 (it) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
EP2087020A4 (en) 2006-11-17 2010-11-24 Agency Science Tech & Res POROUS POLYMERIC MATERIAL COMPRISING A CROSS-LINING AGENT
CN101389342B (zh) 2006-12-05 2012-08-08 株式会社糖质科学研究所 用于变性关节炎的治疗剂
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
WO2009111159A2 (en) 2008-03-03 2009-09-11 New York University Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
JP4739420B2 (ja) * 2008-03-31 2011-08-03 裕昭 乾 ヒト胚の体外受精及び培養用培養液及びヒト胚の体外受精及び培養方法
JP5758797B2 (ja) 2008-04-04 2015-08-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション アルキル化半合成グリコサミノグリカンエーテルならびにその製造および使用方法
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
WO2010078648A1 (en) * 2009-01-07 2010-07-15 Robert John Petrella Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
US20100178317A1 (en) 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US8979821B2 (en) 2009-04-14 2015-03-17 Fezza Family Properties, Llc Lacrimal filler
US20100303915A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Therapeutic opthalmic emulsions
WO2010139954A1 (en) 2009-06-05 2010-12-09 Wei Edward Tak Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid
WO2011031852A1 (en) 2009-09-10 2011-03-17 Boston Foundation For Sight Sodium channel blocker delivery system with scleral lens
CN102781463A (zh) 2009-10-07 2012-11-14 戈诺珍公司 用于皮肤再生的方法和组合物
US20110171310A1 (en) 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
PL3078388T3 (pl) 2010-03-22 2019-08-30 Allergan, Inc. Usieciowane hydrożele do powiększania tkanek miękkich
US20130209531A1 (en) 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
US20130303695A1 (en) 2010-09-02 2013-11-14 Heather Sheardown Hyaluronic acid-containing biopolymers
KR20170018462A (ko) 2010-09-10 2017-02-17 산텐 세이야꾸 가부시키가이샤 P2y2 수용체 작동약 및 히알루론산 또는 그 염을 조합한 것을 특징으로 하는 드라이 아이 치료제, 드라이 아이의 치료 방법, 및 그 용도
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
WO2012143876A1 (en) * 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
GB201118586D0 (en) 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
DK2596796T3 (da) 2011-11-24 2014-01-27 Quimera Ingenieria Biomedica S L Kompleks opnået af hyaluronsyre eller et salt deraf samt chondroitinsulfatblandinger
US20150018305A1 (en) 2012-02-22 2015-01-15 Hyaluronan Research Institute, Inc. Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active ingredient
US20150037422A1 (en) 2012-02-22 2015-02-05 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
UA113434C2 (uk) 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
EP3517100B1 (en) 2013-02-01 2020-09-09 Allergan, Inc. Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
US9226938B2 (en) 2013-03-14 2016-01-05 RMG Rehabilitation Management Group, LP Combinatorial therapy for treatment of osteoarthritis of the knee
JP6418697B2 (ja) 2013-03-25 2018-11-07 国立大学法人東京農工大学 植物の栽培方法
ITMI20130883A1 (it) 2013-05-30 2014-12-01 Eurores S R L Composizioni farmaceutiche comprendenti collagene e sodio ialuronato
PT3019177T (pt) 2013-07-10 2020-12-30 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
CA2931039C (en) 2013-11-20 2022-07-12 Mary Lynch Compositions and methods for treatment of ocular inflammation and pain
US9187576B2 (en) 2013-11-25 2015-11-17 Deuteria Biomaterials, Llc Deuterium-enriched hyaluronan
FR3015290B1 (fr) 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine
ES2871199T3 (es) 2015-09-24 2021-10-28 Matrix Biology Inst Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas

Similar Documents

Publication Publication Date Title
JP2019214632A5 (cg-RX-API-DMAC7.html)
JP2006516032A5 (cg-RX-API-DMAC7.html)
Rubin Mucolytics, expectorants, and mucokinetic medications
Tavassoly et al. Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection
JP5504302B2 (ja) ウイルスの固定化及び安定化
Garantziotis et al. The role of hyaluronan in the pathobiology and treatment of respiratory disease
Irvin et al. Characterization of the Pseudomonas aeruginosa pilus adhesin: confirmation that the pilin structural protein subunit contains a human epithelial cell-binding domain
Clunes et al. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
Henke et al. Mucolytics in cystic fibrosis
Tiwari et al. Role of heparan sulfate in sexually transmitted infections
JP5785085B2 (ja) 癒着を処置又は防止するためのポリペプチド
JP2018525423A5 (cg-RX-API-DMAC7.html)
KR20200136980A (ko) 리신-항미생물 펩타이드(amp) 폴리펩타이드 작제물, 리신, 이를 인코딩하는 단리된 폴리뉴클레오타이드 및 이의 용도
JP2005504804A5 (cg-RX-API-DMAC7.html)
JP2024123123A (ja) 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用
JP2003534036A (ja) 中耳手術における使用のための粘弾剤
Nagl et al. N-chlorotaurine, a promising future candidate for topical therapy of fungal infections
KR20090060348A (ko) 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
Teh et al. Aspergillus sinusitis in patients with AIDS: report of three cases and review
Contini et al. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application
CY1111939T1 (el) Φαρμακευτικο στερεο παρασκευασμα που περιλαμβανει βενζαζεπινες και μεθοδος παρασκευης αυτου
KR20190072579A (ko) 폴리믹신-알기네이트 올리고머 콘주게이트
US20020032172A1 (en) Use of dextran and other polysaccharides to improve mucus clearance
WO2016065083A1 (en) Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
CA2382259A1 (en) Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto